CREST Data To Support Abbott’s Bid For Expanded Carotid Stent Labeling

Abbott will use data from the large CREST trial to seek an FDA panel recommendation this week in favor of significantly expanding its labeling for the RX Acculink carotid stent system to address more patients at risk for stroke.